Methods for testing vaccine candidates against bacterial infection in rodents

Immunogenic lipopeptides comprising T-helper and B-cell epitopes

STREPTOCOCCUS EQUI COMPOSITIONS AND METHODS OF USE

Influenza immunogen and vaccine

Vaccine composition comprising il-12 adjuvant encapsulated in controlled-release microsphere

Immunstimulating lipid formulation

Receptor specific transepithelial transport of therapeutics

Gene expression vaccine

Vaccines for the rapid response to pandemic avian influenza

Vaccines for immunization against

Vaccine compositions and methods of treating coronavirus infection

Recombinant double-stranded RNA phage, and use of the same

Mycoplasma gallisepticum formulation

Sphingolipids polyalkylamine conjugates for use in transfection

Sphingoid polyalkylamine conjugates for vaccination

Induction of mucosal immunity by vaccination via the skin route

Clinical method for the immunomodulatory and vaccine adjuvant use of poly-ICLC and other dsRNAs

Functionally reconstituted viral membranes containing adjuvant

Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination

Peptides for delivery of mucosal vaccines

Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation

H3 equine influenza A virus

Use of inactive immunosuppressive and/or angiogenic immunogenic proteins, for producing secretory IgA's

Inactivated influenza virus vaccine for nasal or oral application

Recombinant double-stranded RNA phages and uses thereof

Intranasal delivery of pneumococcal polysaccharide vaccines

Immunization of non-human mammals against

Cold-adapted equine influenza viruses

Anti-pneumococcal preparations

Influenza immunogen and vaccine

Methods of preventing and treating RSV infections and related conditions

Use of sendai virus as a human parainfluenza vaccine

Streptococcus equi vaccine compositions and method of use

Immunological combination compositions and methods

Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

Intranasal immunization with detoxified lipooligosaccharide from nontypeable or

Mucosal vaccines with chitosan adjuvant and meningococcal antigens

Methods for tailoring the immune response to an antigen or immunogen

Method for preparation of vesicles loaded with biological material and different uses thereof

Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes

Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes

Antigen delivery vectors and constructs

Influenza hemagglutinin and neuraminidase variants

Treatment of mammalian reaction of IgE interactions

Local nasal immunotherapy with allergen strip for allergic rhinitis

Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences

Influenza hemagglutinin and neuraminidase variants

Use of bioadhesives and adjuvants for the mucosal delivery of antigens

Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax

Nebulization of monoclonal antibodies for treating pulmonary diseases

Intranasal recombinant Salmonella vaccine encoding heterologous polysaccharide antigens

Compositions and methods for treatment of microbial infections

Bacterial spores

Use of hyaluronic acid polymers for mucosal delivery of vaccine and adjuvants

Potent mucosal immune response induced by modified immunomodulatory oligonucleotides

Compositions and methods to initiate or enhance antibody and major-histocompatibility class I or class II-restricted t cell responses by using immunomodulatory, non-coding rna motifs

Non-spreading pestivirus

Use of invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo

Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination

Microparticles with adsorbent surfaces, methods of making same, and uses thereof

Chylamydia vaccine

Replicons of pestviruses that do not express C and or E1 protein and infectious viral particles containing same, that can be used in vaccines

Intranasal influenza virus vaccine

Inactivated influenza virus vaccine for nasal or oral application

Microparticles with adsorbent surfaces, methods of making same, and uses thereof

Pharmaceutical composition for administration to mucosal surfaces

Functional mutations in respiratory syncytial virus

Hiv vaccine and method of use

Adjuvant composition comprising FHA protein or a fragment of FHA protein in its free form

Immunological adjuvant

Multi plasmid system for the production of influenza virus

Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions

Measles subunit vaccine

Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus

Isolation and characterization of the operon (ETEC-CS4 pili) and methods of using same

Adjuvanted influenza vaccine

DNA immunization against infection

Recombinant RSV virus expression systems and vaccines

Delivery of physiological agents with in-situ gels comprising anionic polysaccharides

Equine herpesvirus vaccine

Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa

Immunogenic compositions for protection against Chlamydial infection

Methods and interferon deficient substrates for the propagation of viruses

Subunit vaccine against respiratory syncytial virus infection

DNA vaccine expressing HA1 of equine-2 influenza virus

Immune response induction method

Hepatitis b virus surface antigen as a mucosal immunostimulator and the resulting formulations

Method and compositions for treatment of insulin-dependant diabetes mellitus

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus

Method of obtaining protection against bystander allergen

Vaccines using pattern recognition receptor-ligand:lipid complexes

Peptide-based vaccine for influenza

Adjuvant for vaccine composition

Kexin-based vaccines to prevent or treat fungal infections